Conformal Medical

Conformal Medical

Private
Nashua, New HampshireHealthcare & Life Scienceshttps://www.conformalmedical.com

Last Round

Series D

Extension

Aug 12, 2025

Total Funding Raised

$161M

Company Overview

Conformal (Therapeutic Devices) is a medical technology company that develops innovative implant devices aimed at preventing strokes in patients with atrial fibrillation by conforming to individual anatomies for effective atrial appendage closure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

left atrial appendage occlusionLAAOLAAO devicestroke preventionatrial fibrillationAFibstructural heart deviceheart occluderleft atrial appendage occluderinterventional cardiologyconformable implantfoam-based implantimplantable devicecardiovascular deviceclinical trial

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Conformal Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Conformal Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series D ExtensionAug 12, 2025
Series DJun 5, 2023
Series CAug 6, 2020
Series BDec 3, 2018

Conformal Medical Investors

Notable investors and investment history

InvestorRounds
CHVSeries B, Series C
Sprig EquitySeries D
Fidelity Management & Research CompanySeries D, Series C
Catalyst Health VenturesSeries D, Series C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    CLAAS AcuFORM device for LAAO is in a US IDE clinical trial.

  • Jan 17, 2025

    Presenting GLACE Study results at the Annual AF Symposium on January 17, 2025.

Conformal Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Conformal Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Conformal Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersNashua, New Hampshire
Employee Range58
Year Founded2016
Last FundingAug 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.